Fig. 1
Ballistics and exposure of healthy tissues to radiation impact the radio-induced immune response and RT efficacy. SRT shield radiotherapy, TAM tumor-associated macrophage, Mono monocyte, MonoACT activated monocytes, CRT conformal radiotherapy, Treg regulatory T cell, IFN-I type I interferon, TIL tumor-infiltrating lymphocyte, Cxcl10 c-x-c motif chemokine ligand 10, Il interleukin, RT radiotherapy